AMGEN
Amgen Inc.
Application Filed: 2005-10-19
Trademark Application Details
REGISTERED AND RENEWED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78736498 |
| Registration Number | 3226919 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | B |
| Attorney Name | Timothy J. Gaul |
| Law Office Assigned | M80 |
| Employee Name | FAIRBANKS, RONALD L |
Timeline
| 1984-04-00 | Date of First Use |
| 2005-10-19 | Application Filed |
| 2007-01-23 | Published for Opposition |
| 2007-04-10 | Trademark Registered |
| 2017-03-28 | Location: GENERIC WEB UPDATE |
| 2017-03-28 | Status: Live/Registered |
| 2017-04-10 | Renewal Date |
| 2019-03-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Amgen Inc. |
| Address | One Amgen Center Drive Thousand Oaks DE 913201789 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 36 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | House mark for a full line of pharmaceuticals; and pharmaceuticals, including human recombinant erythropoietin and erythropoiesis stimulating protein; pharmaceuticals for use in stimulating production of red blood cells, white blood cells or platelets; pharmaceuticals for modulating calcium, phosphorus, or parathyroid hormone levels in the blood or for treatment of hyperparathyroidism, hypercalcemia or bone metabolism related disorders and diseases; pharmaceuticals for treating human immune diseases and conditions; pharmaceuticals for the treatment of viral infections, neoplastic, metabolic, autoimmune or inflammatory disorders; [ pharmaceuticals for the treatment of injury to epithelial cells and tissues; pharmaceuticals for modulating weight loss, regulating reproductive function and promoting wound healing, and for use in the treatment of obesity, diabetes, hypertension, dyslipidemia and cardiovascular diseases and infertility; and support kits for patients afflicted with autoimmune or inflammatory disorders, comprised primarily of materials for wound dressing and sterilization and a device for delivery of a drug; ] one or more of the aforementioned pharmaceutical preparations sold in prefilled syringes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2005-10-25 | 1 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2006-04-23 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2006-05-01 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2006-05-01 | 4 GNRT F:First Action |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2006-09-26 | 5 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2006-09-26 | 6 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2006-10-31 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2006-10-31 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2006-11-01 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2006-11-16 | 10 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2006-12-05 | 11 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2006-12-05 | 12 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2007-01-03 | 13 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2007-01-23 | 14 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2007-04-10 | 15 R.PR A:Allowance for Publication |
| TEAS SECTION 8 & 15 RECEIVED | 2013-03-25 | 16 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2013-04-05 | 17 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | 2013-03-25 | 18 815F I:Incoming Correspondence |
| REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2013-04-05 | 19 C15P O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2013-04-05 | 20 NA85 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2016-04-10 | 21 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2017-03-27 | 22 E89R I:Incoming Correspondence |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2017-03-28 | 23 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2017-03-28 | 24 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2017-03-28 | 25 NA89 E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-08-02 | 26 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-08-02 | 27 ARAA I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-03-07 | 28 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-03-07 | 29 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-04-29 | 30 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-04-29 | 31 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-04-29 | 32 ARAA I:Incoming Correspondence |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2022-04-29 | 33 EWAF I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-04-29 | 34 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-04-29 | 35 CHAN I:Incoming Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 